Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Strata Critical Medical (SRTA) FCF Margin (2020 - 2025)

Strata Critical Medical (SRTA) has disclosed FCF Margin for 6 consecutive years, with 11.85% as the latest value for Q4 2025.

  • Quarterly FCF Margin rose 6821.0% to 11.85% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 20.33% through Dec 2025, up 804.0% year-over-year, with the annual reading at 24.88% for FY2025, 214.0% down from the prior year.
  • FCF Margin for Q4 2025 was 11.85% at Strata Critical Medical, up from 76.23% in the prior quarter.
  • The five-year high for FCF Margin was 4.78% in Q3 2023, with the low at 80.07% in Q4 2024.
  • Average FCF Margin over 5 years is 31.69%, with a median of 23.9% recorded in 2022.
  • The sharpest move saw FCF Margin tumbled -7320bps in 2021, then skyrocketed 6821bps in 2025.
  • Over 5 years, FCF Margin stood at 24.44% in 2021, then increased by 2bps to 23.9% in 2022, then increased by 18bps to 19.63% in 2023, then tumbled by -308bps to 80.07% in 2024, then surged by 85bps to 11.85% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 11.85%, 76.23%, and 0.96% for Q4 2025, Q3 2025, and Q2 2025 respectively.